BGU researchers are on the verge of a breakthrough that is bringing the world closer to a cure for diabetes.
Researchers at BGU’s Clinical Islet Laboratory are pursuing three major goals: transplants and new drugs, gene therapy, and the creation of a “transgenic” mouse that can tolerate human material for experimentation. They’re working on new drugs based on the alpha-1-antitrypsin (AAT) protein that reduces inflammation. Recent clinical trials demonstrated that infusion of AAT in recently diagnosed type 1 diabetes patients could eventually eliminate the need for insulin injections. A new clinical trial is under way to evaluate AAT dosing levels and duration.
Diabetes Videossee all videos
Diabetes Newssee all news
Mom Teams-Up with BGU Researcher to Cure Diabetes
Searching for better diabetes treatment for her son, a San Antonio mom connects with Dr. Eli Lewis.
Working with Local Physicians on Diabetes Treatment
Philadelphia hosted a clinical trial of a breakthrough diabetes protocol by BGU’s Dr. Eli Lewis.
A Promising Treatment for Type 1 Diabetes
Infusions of AAT could end insulin injections for people newly diagnosed with type 1 diabetes.